Skip to main content
. 2022 Jan 6;24(1):23–30. doi: 10.1007/s11886-021-01621-0

Table 2.

Proposed updated treatment algorithm for recurrent pericarditis including rilonacept

Pericarditis event Treatment
Acute pericarditis

- NSAIDs (week(s))

- Colchicine (3 months)

Recurrent pericarditis — first event

- NSAIDs (weeks to months)

- Colchicine (≥ 6 months)

Recurrent pericarditis — second event or beyond

- NSAIDs (weeks to months)

- Colchicine (≥ 6 months)

- Rilonacept can be considered, including ahead of corticosteroids, and other drugs if intolerant

Recurrent pericarditis — colchicine resistance and/or corticosteroid dependent

- NSAIDs

- Colchicine

- Rilonacept, including while tapering down other agents especially corticosteroids

Recurrent pericarditis — rilonacept failure

- Consider alternative interleukin-1 inhibitor (such as anakinra)

- Intensify anti-inflammatory combinations

- Pericardiectomy may be considered (last line)